Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Etoposide

U.S. FDA Requirements: Etoposide

Pharmaceutical / Drug Definition : Damages DNA before mitosis by inhibiting topoisomerase II enzyme. This action impairs DNA synthesis and inhibits selected cancer cell growth. Cell-cycle-phase specific.

In the United States, Etoposide is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Etoposide.

Registrar Corp assists Etoposide companies with:

  • FDA Registration Etoposide
  • FDA Listing Etoposide
  • FDA Label Requirements and Exceptions Etoposide
  • FDA Import Information Etoposide
  • FDA Detentions Etoposide (Etoposide Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Etoposide (Etoposide Suppliers)
       - Processors Etoposide
       - Repackers Etoposide
       - Relabelers Etoposide
       - Exporters Etoposide
       - Importers Etoposide
For more information about Etoposide, simply click below:

Live Help

U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207

Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2017 Registrar Corp
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco